Publication

Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance

Authored by:

Andrews JA, Baker S, Marks F et al.

Full Citation:

Andrews JA, Baker S, Marks F et al. 2019. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance. Lancet Infectious Disease. 19(1).

View Publication

Additional key concepts from this publication:

Antimicrobial-resistant infections are expensive to treat and place an economic burden on families and health systems.

Key Evidence: The costs and health effects of treating typhoid might soon increase dramatically, since the bacteria that causes typhoid is becoming increasingly resistant to the most effective oral antimicrobial drugs, thus requiring treatment with more expensive intravenous antibiotics which may result in more frequent hospitalizations for suspected typhoid cases.